328.24
3.23%
10.28
After Hours:
331.45
3.21
+0.98%
Medpace Holdings Inc stock is traded at $328.24, with a volume of 376.17K.
It is up +3.23% in the last 24 hours and down -4.32% over the past month.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$317.96
Open:
$316.2
24h Volume:
376.17K
Relative Volume:
1.13
Market Cap:
$10.20B
Revenue:
$2.03B
Net Income/Loss:
$339.79M
P/E Ratio:
38.44
EPS:
8.54
Net Cash Flow:
$502.80M
1W Performance:
-0.46%
1M Performance:
-4.32%
6M Performance:
-16.39%
1Y Performance:
+19.70%
Medpace Holdings Inc Stock (MEDP) Company Profile
Name
Medpace Holdings Inc
Sector
Industry
Phone
(513) 579-9911
Address
5375 MEDPACE WAY, CINCINNATI, OH
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-14-24 | Initiated | Redburn Atlantic | Buy |
Sep-27-24 | Downgrade | UBS | Buy → Neutral |
Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
Aug-01-24 | Initiated | Truist | Hold |
May-29-24 | Initiated | TD Cowen | Buy |
May-28-24 | Initiated | Mizuho | Buy |
Apr-23-24 | Upgrade | Jefferies | Hold → Buy |
Mar-18-24 | Initiated | Deutsche Bank | Hold |
Feb-15-24 | Upgrade | UBS | Neutral → Buy |
Oct-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
May-08-23 | Upgrade | Guggenheim | Neutral → Buy |
Oct-27-22 | Upgrade | UBS | Sell → Neutral |
Sep-07-22 | Initiated | UBS | Sell |
May-24-22 | Initiated | Guggenheim | Neutral |
Aug-05-21 | Resumed | Credit Suisse | Outperform |
Oct-02-20 | Upgrade | Truist | Hold → Buy |
Jun-08-20 | Upgrade | Robert W. Baird | Underperform → Neutral |
May-13-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Apr-30-20 | Upgrade | SunTrust | Sell → Hold |
Apr-20-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
Mar-17-20 | Downgrade | SunTrust | Hold → Sell |
Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
Oct-31-18 | Upgrade | SunTrust | Hold → Buy |
Sep-17-18 | Initiated | SunTrust | Hold |
Jul-31-18 | Upgrade | William Blair | Mkt Perform → Outperform |
Nov-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
Sep-29-17 | Initiated | Raymond James | Mkt Perform |
Jul-10-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Medpace Holdings Inc Stock (MEDP) Latest News
MEDP Investors Have Opportunity to Join Medpace Holdings, Inc. F - GuruFocus.com
MEDP Investigation Notice: Kessler Topaz Meltzer & Check, LLP En - GuruFocus.com
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC - GlobeNewswire
What Makes Medpace Holdings (MEDP) a Good Holding? - Insider Monkey
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Investors to Learn More About the Investigation - AccessWire
Medpace Holdings, Inc. (NASDAQ:MEDP) Stake Lowered by Integrated Advisors Network LLC - MarketBeat
Wolf Haldenstein Adler Freeman & Herz LLP announces that it - GlobeNewswire
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Medpace Holdings, Inc. for potential violations of securities laws - GlobeNewswire Inc.
Medpace: A Compelling Long-Term Opportunity Amid Short-Term Headwinds (NASDAQ:MEDP) - Seeking Alpha
Stephens Investment Management Group LLC Acquires 3,889 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat
Medpace cut to neutral by Baird, slowed revenue growth cited - MSN
abrdn plc Reduces Position in Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Medpace Holdings, Inc. for potential violations of securities laws - AccessWire
MEDP Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm - PR Newswire
International Assets Investment Management LLC Buys 57,265 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat
Bragar Eagel & Squire, P.C. Is Investigating Aviat, - GlobeNewswire
Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - AccessWire
Medpace Holdings, Inc. (NASDAQ:MEDP) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
China Universal Asset Management Co. Ltd. Purchases 2,322 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Stockholders to Learn More About the Investigation - AccessWire
Medpace: Long-Term Owners Have To Stomach Short-Term Volatility - Seeking Alpha
Boston Trust Walden Corp Has $43.28 Million Position in Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat
Medpace: Buy The Short-Term Pain For Long-Term Gains (NASDAQ:MEDP) - Seeking Alpha
Backlog Conversion Likely to Aid Medpace's (MEDP) Q2 Earnings - MSN
MEDP Investors Have Opportunity to Join Medpace Holdings, Inc. Fraud Investigation with the Schall Law Firm - Marketscreener.com
William Blair Issues Positive Outlook for Medpace Earnings - MarketBeat
Argent Capital Management LLC Increases Holdings in Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat
FY2024 Earnings Forecast for Medpace Issued By William Blair - MarketBeat
Medpace (NASDAQ:MEDP) Downgraded by Baird R W to Hold - MarketBeat
Medpace Holdings, Inc. (NASDAQ:MEDP) Q3 2024 Earnings Call Transcript - Insider Monkey
TD Cowen Trims Medpace (NASDAQ:MEDP) Target Price to $372.00 - MarketBeat
Medpace stock downgraded by Baird amid funding challenges & weaker growth outlook - Investing.com South Africa
NASDAQ: MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm - PR Newswire
Earnings call: Medpace reports growth amidst increased cancellations By Investing.com - Investing.com South Africa
Earnings call: Medpace reports growth amidst increased cancellations - Investing.com India
Medpace Holdings, Inc. (NASDAQ:MEDP) Stock Position Raised by Lecap Asset Management Ltd. - MarketBeat
Medpace Q3 2024 Earnings Preview - MSN
Medpace (NASDAQ:MEDP) Cut to Neutral at Robert W. Baird - MarketBeat
Medpace downgraded to Neutral from Outperform at Baird - TipRanks
Medpace Holdings Inc (MEDP) Q3 2024 Earnings Call Highlights: Strong Revenue and Income Growth ... - Yahoo Finance
TD Cowen maintains Buy rating on Medpace stock - Investing.com
NASDAQ: MEDP Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm - Business Wire
Medpace Earnings: Shares Fall Due to Cancellations From Biotech Funding Issues - Morningstar
How Medpace Just Blew Up Expectations For Double-Digit Sales Growth In 2025 - MSN
Medpace's (MEDP) "Outperform" Rating Reiterated at William Blair - MarketBeat
Medpace (NASDAQ:MEDP) Shares Gap DownHere's Why - MarketBeat
Medpace Stock Drop. Biotech’s Doldrums Are to Blame. - MSN
Medpace Stock Drops. Biotech’s Doldrums Are to Blame. - Barron's
TD Cowen maintains Buy rating on Medpace stock By Investing.com - Investing.com UK
Medpace (NASDAQ:MEDP) Issues Quarterly Earnings Results, Beats Estimates By $0.24 EPS - MarketBeat
Medpace revenue increases 8.3% to USD 533.3M in Q3 2024 - Medical Buyer
Medpace Holdings Inc Stock (MEDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):